Cedric Francois, Chief Executive Officer at Apellis Pharmaceuticals, Inc. (APLS), sold 450,000 shares at $28.39 ($12.7M) on 2025-08-28, disclosed to the SEC on 2025-08-29.
Open-market sale of $12.7M APLS by Chief Executive Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $28.19 | 175,037 | $4.9M | 38.8% |
| 2 | $28.19 | 175,037 | $4.9M | 38.8% |
| 3 | $28.39 | 49,963 | $1.4M | 11.2% |
| 4 | $28.39 | 49,963 | $1.4M | 11.2% |
| Total | $28.23 avg | 450,000 | $12.7M | 100% |
| Filing → |
| APLS | SELL | 2026-01-15 | $226K | — | Filing → |
| APLS | SELL | 2025-07-18 | $797K | — | Filing → |
| APLS | SELL | 2025-07-16 | $5.6M | — | Filing → |